Korea Investment CORP Sells 31,706 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Korea Investment CORP reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 9.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 301,911 shares of the medical equipment provider's stock after selling 31,706 shares during the quarter. Korea Investment CORP owned approximately 0.08% of Intuitive Surgical worth $157,585,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Ausdal Financial Partners Inc. lifted its stake in shares of Intuitive Surgical by 3.0% in the 4th quarter. Ausdal Financial Partners Inc. now owns 1,977 shares of the medical equipment provider's stock valued at $1,032,000 after purchasing an additional 57 shares during the period. Mizuho Securities Co. Ltd. raised its holdings in Intuitive Surgical by 150.0% in the fourth quarter. Mizuho Securities Co. Ltd. now owns 300 shares of the medical equipment provider's stock worth $158,000 after purchasing an additional 180 shares in the last quarter. UNIVEST FINANCIAL Corp lifted its position in Intuitive Surgical by 5.2% during the fourth quarter. UNIVEST FINANCIAL Corp now owns 9,415 shares of the medical equipment provider's stock valued at $4,914,000 after buying an additional 469 shares during the period. Murphy & Mullick Capital Management Corp bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $975,000. Finally, Mitsubishi UFJ Trust & Banking Corp increased its stake in shares of Intuitive Surgical by 1.5% in the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 314,681 shares of the medical equipment provider's stock worth $164,251,000 after acquiring an additional 4,791 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.

Remove Ads

Insider Transactions at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company's stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Jamie Samath sold 94 shares of the business's stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 in the last 90 days. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on ISRG. UBS Group upped their price objective on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. JPMorgan Chase & Co. upped their price target on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a research note on Friday, January 24th. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Barclays increased their target price on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Morgan Stanley raised Intuitive Surgical from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $611.86.

Intuitive Surgical Stock Down 3.2 %

NASDAQ:ISRG traded down $16.06 on Friday, hitting $491.84. The stock had a trading volume of 1,966,546 shares, compared to its average volume of 1,527,047. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $175.18 billion, a price-to-earnings ratio of 76.73, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business's 50-day simple moving average is $556.28 and its two-hundred day simple moving average is $532.68.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.